Reviva Pharmaceuticals Holdings (RVPH)
NASDAQ:RVPH
US Market
Holding RVPH?
Track your performance easily

Reviva Pharmaceuticals Holdings (RVPH) Income Statement

213 Followers

Reviva Pharmaceuticals Holdings Income Statement

Last quarter (Q2 2024), Reviva Pharmaceuticals Holdings's total revenue was $―, a decrease of ― from the same quarter last year. In Q2, Reviva Pharmaceuticals Holdings's net income was $-7.86M. See Reviva Pharmaceuticals Holdings’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
-----$ 0.00
Cost of Revenue
------
Gross Profit
------
Operating Expense
$ 20.91M$ 39.50M$ 28.23M$ 10.10M$ 2.43M$ 376.86K
Operating Income
$ -36.75M$ -39.50M$ -28.23M$ -10.10M$ -2.43M$ -376.86K
Net Non Operating Interest Income Expense
$ 343.08K-$ -182.80K-$ -1.45M$ -469.17K
Other Income Expense
$ -741.28K$ 239.22K$ -194.71K$ -1.59M$ -105.18K-
Pretax Income
$ -35.49M$ -39.24M$ -28.24M$ -8.52M$ -3.78M$ -846.03K
Tax Provision
$ 7.52K$ 16.95K$ 20.78K$ 6.00K$ 800.00$ 800.00
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -35.51M$ -39.26M$ -28.26M$ -8.52M$ -3.78M$ -846.83K
Basic EPS
$ -1.33$ -1.65$ -1.25-$ -1.24$ -0.31
Diluted EPS
$ -1.33$ -1.65$ -1.25-$ -1.24$ -0.31
Basic Average Shares
$ 111.37M$ 23.80M$ 19.52M-$ 3.06M$ 2.77M
Diluted Average Shares
$ 111.37M$ 23.80M$ 19.52M-$ 3.06M$ 2.77M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 20.91M$ 39.50M$ 28.23M$ 10.10M$ 2.43M$ 376.86K
Net Income From Continuing And Discontinued Operation
$ -35.51M$ -39.26M$ -28.26M$ -8.52M$ -3.78M$ -846.83K
Normalized Income
$ -7.77M--$ -6.73M-$ -846.83K
Interest Expense
-----$ 469.37K
EBIT
$ -20.16M$ -39.74M$ -28.23M$ -8.51M$ -2.33M$ -376.66K
EBITDA
$ -20.16M$ -39.74M$ -28.23M$ -8.51M$ -2.33M$ -376.01K
Currency in USD

Reviva Pharmaceuticals Holdings Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis